How We Help:
- Evaluation of in-licensing assets, products, companies
- Developing out-licensing commercial propositions
- Creating product/portfolio commercial strategies and options
- On-going commercial advisor
- Second pair of experienced eyes
Recent Client Types
- Emerging biotech
- European manufacturers
- Major management consulting firm
- Single-family office investment firm
- Global healthcare investment firm
Recent Therapeutic Areas
- Anti-infective
- Beauty Care
- Cardio-Respiratory
- Critical Care
- Dermatology
- Gastrointestinal
- Medical Aesthetics
- Microbiome
- Over-the-counter drugs
- Womens Healthcare
Past Therapeutic Areas
My biopharma commercial assessment teams evaluated 130 to 200 compounds, companies, and deals a year across fifteen therapeutic areas over a ten-year period:
- Anti-Infection
- Cardiology
- CNS
- Dermatology
- Eyecare
- Gastrointestinal
- Medical Aesthetics
- Metabolic Disorders
- Oncology
- Orphan/Rare
- Pain
- Respiratory
- Rheumatology
- Urology
- Womens Healthcare